Course Development Handbook
Appendix 7
s
Module specification template
Title
Code
Level
Credit rating
Pre-requisites
Type of module
Aims
Learning
outcomes/objectives
Content
Comments/notes
Gastrointestinal and Hepatic Diseases
CLM06
7
20
Graduate Registered Pharmacists
The module is delivered within the workplace using the
module material provided by the London, Eastern and
South East Clinical Pharmacy Service.
1. To allow pharmacists to critically evaluate and apply
their pharmacological and pharmaceutical knowledge and
skills to the treatment of patients with gastrointestinal and
hepatic disease.
2. To provide pharmacists with a comprehensive
understanding of how the signs, symptoms and laboratory
investigations can aid the monitoring of both disease
process and drug therapy.
3. To provide pharmacists with the knowledge and skills
required to provide pharmaceutical care for patients with
gastrointestinal or hepatic disease.
1. To evaluate clinical and laboratory test results in order to
critique the drug treatment of individuals presenting with
either upper gastrointestinal or hepatic disease,
2. To demonstrate a comprehensive understanding of the
pharmacological and pharmaceutical knowledge and to
apply this to the rationalisation of treatment choices
involved in the management of common gastrointestinal
and hepatic conditions.
3. To critically evaluate the patient's response to the
therapy prescribed in order to identify potential and
actual drug related problems.
4. To demonstrate competence in the provision of
pharmaceutical care to patients with gastrointestinal and
hepatic disorders.
5. To demonstrate the ability to make sound judgements in
relation to the drug treatment of patients with these
conditions and to communicate this effectively to other
health care professions.
6. To demonstrate the ability to critically evaluate the
risks/benefit of pharmaceutical intervention and to
communicate this effectively to patients.
Anatomy and physiology of gastrointestinal and liver
systems in order to illustrate the process of adaption,
enterohepatic circulation and hepatic shunting. Aetiology
and pathophysiology of peptic ulceration and the common
hepatic diseases. Interpretation of liver function tests and
criteria used to diagnose both liver and upper
gastrointestinal disease including the associated signs and
symptoms.
52
Course Development Handbook
Appendix 7
Content (cont.)
Teaching and learning
strategies
Learning support
Assessment tasks
Brief description of module
content and/or aims
(maximum 80 words)
Area examination board to
which module relates
Management of complications of liver disease; acute
bleeding, ascites, encephalopathy. Management of upper
gastrointestinal ulceration; oesophagitis and peptic
ulceration. Design of acute and maintenance treatment
regimens. Prevention and treatment of drug induced
gastrointestinal or hepatic disease.
Details of the standard module format are provided in the
programme specification. The material is presented in
electronic form and is normally provided to the student to
work through systematically under the supervision of an
appropriate senior clinical practitioner. Periodic meetings
with the local tutor allows understanding and the
application of this information to patient care to be
reviewed and the ability of the individual to perform key
skills to be evaluated.
Material is presented as a computer package to direct the
student learning. Students are then required to complete an
array of practice activities (see programme specification)
and demonstrate their competence to perform an array of
clinical tasks before being eligible to register for the module
assessment. Students are required to read and evaluate
articles contained within the appropriate medical journals in
addition to the appropriate chapters contained within the
general indicative texts listed below:
Kumar P, Clark M. Clinical Medicine(5th Edition)
Edinburgh. WB Sauders 2002.
Doods L. Drugs in Use. 3rd Edition. The Pharmaceutical
Press 2002.
Walker R, Edwards C. Clinical Pharmacy and Therapeutics.
3rd Edition. Churchill Livingstone. 2002.
The assessment strategy embraces the concept of “fitness
for purpose” so that students are required to demonstrate
their ability to apply the knowledge and skills acquired to
resolve a range of clinical problems. This requires the
student to gather and critically evaluate clinical data prior to
engaging in complex decision making, culminating in the
provision of advice to health care professionals and
patients. These problems are designed to reflect scenarios
routinely encountered in clinical practice. This requires
students to complete an objective structured clinical
examination (OSCE), comprising of 10 clinical scenarios,
reflecting clinical practice in the module being studied. To
pass the module students must satisfy the criteria in 7 of the
ten stations, and present an acceptable portfolio.
The module details the signs, symptoms and biochemical
tests associated with patients with gastrointestinal and
hepatic disease.
A comprehensive, evidence-based review of the available
treatment follows. Students are required to apply this
knowledge to resolve drug related problems in patients
housed in general medical wards.
Course Examination Board only (normally March and
September each year)
53
Course Development Handbook
Appendix 7
Module team/authors/
coordinator
Semester offered, where
appropriate
Site where delivered
Date of first approval
Date of last revision
Date of approval of this
version
Version number
Replacement for previous
module
Field for which module is
acceptable and status in that
field
Course(s) for which module
is acceptable and status in
that course
School home
External examiner
Produced by practitioners specialising in gastrointestinal
and hepatic disease. Module leader –
Sotiris Antoniou Senior Pharmacist, Barts and the London
NHS Trust.
Not applicable.
The School of Pharmacy and Biomolecular Sciences of the
university is responsible for the designing and organising
the assessment process and the overall standard of the
course. The local hospitals have responsibility for the
tuition, which is co-ordinated by the London, Eastern and
South East Clinical Pharmacy Service.
August 1994
September 2004
3
PG Certificate in Applied Therapeutics. PG Diploma in
Clinical Pharmacy Practice.
Pharmacy and Biomolecular Sciences
Mr Jonathan Silcock. March 2004 - 2008
54